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Background: The current study examined the psychometric properties of the 12-item 
French-language version of the Questionnaire on Smoking Urges (QSU-12), a widely used 
multidimensional measure of cigarette craving. 
Methods: Daily smokers (n=230) completed the QSU-12, the Fägerstrom Test for Nicotine 
Dependence, and items about addiction-related symptoms. Additional participants (n=40) 
completed the QSU-12 and the Fägerstrom Test for Nicotine Dependence and were assessed 
for expired carbon monoxide. 
Results: Consistent with studies validating the English version of the scale, confirmatory fac-
tor analyses supported a two-factor solution in the French version of the scale. Good scale and 
subscales reliabilities were observed, and convergent validity was evidenced through relation-
ships with dependence and addiction-related symptoms. 
Conclusion: The French-language version of the QSU-12 is an adequate instrument to assess 
the multidimensional construct of craving in both research and clinical practice. 
Keywords: tobacco, smoking, nicotine, craving, measurement model, psychometrics, confirma-
tory factor analyses, carbon monoxide, addiction
Introduction
Craving is an important part of the experience of people with addiction and is listed 
as one of the features of psychoactive substance dependence in the International 
Classification of Diseases1 and in the Diagnostic and Statistical Manual of Mental 
Disorders.2 Likewise, dominant biopsychological models of addiction consider craving 
to play a core role in the maintenance of addiction.3–6 At the empirical level, craving 
is a predictor of smoking relapse,7–9 and its decrease contributes to the effectiveness 
of pharmacological treatments.10,11 Hence, craving assessment has considerable utility 
for diagnosis and clinical outcomes.12
There have been numerous definitions of craving. For instance, Tiffany has sug-
gested that craving is a subjective motivational state that encourages compulsive 
drug self-administration, hinders efforts to achieve abstinence, and causes a relapse 
following sustained drug abstinence.6 While some authors have restricted the meaning 
of craving to the experience of a strong desire to use a drug,13,14 other have proposed 
conceptions that encompass various affective and cognitive components. Indeed, 
some have considered the anticipation of the drug’s consequences, the intentions 
to use drugs, mental images, and drug-related affects and cognitions as part of the 
concept of craving.4,15–17 This latter conception highlights the multidimensional nature 
of craving.
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Over the last two decades, many studies have evalu-
ated craving by using a single item.18–21 However, such an 
approach limits the assessment of reliability and validity, 
as it restricts craving to an unidimensional construct.12,22 
Addressing these two flaws, the Questionnaire on Smoking 
Urges (QSU)17 is the most widely used multidimensional 
measure of craving for cigarettes. The 32-item English-
language version of the questionnaire was originally devel-
oped to capture various aspects of craving experiences (ie, 
desire to smoke, anticipation of positive reinforcement, 
anticipation of negative reinforcement, intention to smoke). 
In the initial validation study, exploratory factor analysis 
revealed a two-factor solution. Whereas one factor was 
related to the anticipation of relief from negative affect or 
withdrawal symptoms (negative reinforcement), the other 
factor was linked to the intention/desire to smoke and to the 
anticipation of positive outcomes (positive reinforcement). 
This bifactorial structure has been replicated.23,24 Since 
its creation, the QSU has been translated and validated 
in several languages, including Spanish,25 German,26 
and French.27 
Recently, various short versions of the QSU have been 
developed. Short versions are useful for both research and 
clinical purposes (given that long scales are rarely incor-
porated in systematic clinical screening and/or research 
protocols). A 12-item version (QSU-12) was proposed 
by Kozlowski et al28 on the basis of the highest loadings. 
A 10-item version (QSU-10) was then proposed by Cox 
et al29 on the basis of both factor loadings and content cov-
erage. Moreover, some statements were reworded to avoid 
reversed items. Validation studies conducted on both the 
10-item and the 12-item versions corroborated a two-factor 
structure similar to the initial version of the scale.29–33 Short 
versions of the QSU have been translated and validated in 
various languages: Spanish,25 Portuguese,34 Italian,35 and 
Chinese.36
Although this scale has not been validated into French, 
several studies have already used these short versions among 
French-speaking samples.37–39 However, uncertainty still 
abounds regarding the psychometric properties, particularly 
regarding the factor structure of the French short versions of 
the QSU. In the initial validation of the French long version 
of the QSU, exploratory factor analysis (EFA) demonstrated 
a bifactorial structure.27 However, there are a number of 
limitations to EFA, thereby limiting the generalizability of 
these findings. Indeed, although EFA is a useful approach 
when there is an insufficient theoretical and empirical basis to 
specify a model, confirmatory factor analysis (CFA) remains 
necessary to test a specific hypothesis about the structure 
of the data and to determine whether a proposed model 
fits the data well. In the present study, we use the 12-item 
version because it comprises negatively worded items, as 
suggested by the recommendations of the international test 
development.40 
The aim of the current study was to examine the psy-
chometric and structural properties of the French-language 
QSU-12. We thus conducted CFA and explored the internal 
consistency of the scale. An additional sample was recruited 
in order to evaluate convergent validity with expired carbon 
monoxide (CO). This measure allowed us to objectively 
quantify the degree of exposure to one of the major compo-
nents of tobacco smoke.
Methods
Participants
Participants were French-speaking smokers (daily smok-
ers who had smoked at least 100 cigarettes during their 
entire life) aged 18 years and older. They were recruited 
through advertisements posted in French specialized 
forums and research networks. Participants were invited 
to circulate the invitational email to their acquaintances 
(ie, snowball principle emailing). In order to include a 
maximal number of participants, data were collected via 
an online survey (subsample 1). The participants of an 
additional sample (subsample 2) filled in the question-
naires on a written survey. Subsample 2 participants 
were recruited within the framework of a master’s degree 
thesis and, in accordance with the design of that study, 
were instructed not to smoke in the hour prior to the data 
collection. 
All participants gave their consent before starting the 
survey. The study protocol was approved by the ethical 
committee of the Psychology Department of the Université 
catholique de Louvain.
instruments
Participants in subsample 1 were first asked about their 
tobacco consumption (number of cigarettes per day and time 
since the last cigarette was smoked). They then completed the 
French version of the QSU-12.27 Each item was completed 
on a seven-point Likert-type scale from totally disagree (1) 
to totally agree (7). After completing the QSU-12, partici-
pants filled out the French version of the Fagerström Test 
for Nicotine Dependence (FTND),41 which is a six-item 
self-report questionnaire that is widely used to assess the 
level of tobacco dependence. Finally, six supplementary 
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items were generated to assess 1) negative impact of tobacco 
smoking on daily living, 2) frequency of smoking behaviors 
triggered by negative emotional contexts, 3) frequency of 
smoking behaviors triggered by positive emotional contexts, 
4) frequency of smoking behaviors associated with pleasure 
or excitement seeking, 5) loss of control associated with 
smoking, and 6) frequency of intrusive thoughts or mental 
images related to smoking. These items were scored using 
a four-point Likert scale. 
The participants in the subsample 2 were first measured 
for expired CO with the Micro Smokerlyzer® (Bedfont 
Scientific Ltd, Kent, UK), after which they completed ques-
tions about their tobacco consumption, the QSU-12, and the 
FTND. CO is a biological marker of exposure to combus-
tion byproducts via inhalation. When tobacco is ignited and 
inhaled, CO is produced and binds to hemoglobin to form 
carboxyhemoglobin before being expired into the air. The 
half-life of CO is 2–5 hours and it is expressed in parts per 
million.42 
Data analysis
CFA were performed using SPSS AMOS 16® (IBM 
Corporation, Armonk, NY, USA). Three models were 
tested: Model A, a single-factor solution as suggested by 
Kozlowski et al;28 Model B, a correlated two-factor solution 
as suggested by factor analysis on the French version of the 
QSU;27 and Model C, a correlated two-factor solution derived 
from the English versions of the QSU.17,33 It should be noted 
that Model B and Model C differ for only one item, in that 
item 9 of the scale (“I have an urge for a cigarette”) loads on 
the relief of negative affect dimension (Factor 1) in Model 
B and loads on the intention and desire to smoke dimension 
(Factor 2) in Model C. Moreover, internal consistency and 
convergent validity were also evaluated.
Before performing the analysis, we conducted the 
Kolmogorov–Smirnov test on each item of the QSU-12. 
Normality was not achieved for all items (P0.0001). 
Moreover, the standard method of estimation in structural 
equation modeling is maximum likelihood, which assumes 
multivariate normality of manifest variables. As noted by 
Byrne,43 a frequent error when performing CFA is that the 
normality of the data is not taken into account multivari-
ately. In our case, multivariate kurtosis was indeed high, 
with a Mardia’s coefficient44 of 58.172 (with a cut-off value 
of 26.073), indicating a lack of multivariate normality. 
The items of the QSU-12 refer to a sample of psychologi-
cal constructs that can be present or absent with varying 
frequency. This makes nonnormality and  categorization 
problems likely.45,46 Therefore, using standard normal 
theory estimators with these data could produce estima-
tion problems.
Various formulas can be applied to correct for the lack 
of multivariate normality when performing CFA. The most 
appropriate approach is to use an estimation method that 
makes no distributional assumptions, such as the unweighted 
least squares (ULS) estimation method. ULS is analogous to 
ordinary least squares in traditional regression.
Because the covariance matrix might not be as asymp-
totically distributed as chi-square with the ULS method, the 
chi-square test and other fit indexes based on such statistics 
cannot be computed and are thus not reported.47 Instead, 
we used the following fit indices: 1) Goodness-of-Fit Index 
(GFI), 2) Adjusted Goodness-of-Fit Index (AGFI), 3) Par-
simony Goodness-of-Fit Index (PGFI), and 4) Parsimony 
Ratio (PRATIO). Incremental and residual fit indices cannot 
be used with the ULS method.47
GFI is an absolute-fit index with a corresponding 
adjusted version, the AGFI, developed to incorporate a 
penalty function for the addition of free parameters in the 
model.48 The GFI is analogous to R2 and performs better than 
any other absolute-fit index regarding the absolute fit of the 
data.49,50 Both GFI and AGFI have values between 0–1, with 
1 indicating a perfect fit. A value of 0.80 is usually considered 
as a minimum for model acceptance.51 
PGFI and PRATIO are parsimony-based fit measures. 
Absolute fit measures judge the fit of a model per se 
without reference to other models that could be relevant 
in the situation.52 Parsimony-adjusted measures introduce 
a penalty for complicating the model by increasing the 
number of parameters in order to increase the fit. Usually, 
parsimony-fit indices are much lower than other normed-fit 
measures. Values larger than 0.60 are generally considered 
satisfactory.53 
The present context also requires comparing fit across dif-
ferent models that are not necessarily nested (ie, meaning that 
one model is not simply a constrained version of the other). 
Therefore, we also reported the Akaike Information Crite-
rion (AIC),54 the Browne–Cudeck Criterion (BCC),55 and 
the Expected Cross-Validation Index (ECVI),55 which are 
the most suited for comparison of nonnested models.53 AIC, 
BCC, and ECVI are fit measures based on information theory. 
These indices are not used for judging the fit of a single model 
but are used in situations in which one needs to choose from 
several realistic but different models. These indices are a 
function of both model complexity and goodness of fit. For 
these indices, low scores refer to simple well-fitting models, 
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whereas high scores refer to complex poor-fitting models. 
Therefore, in a comparison-model approach, the model with 
the lower score is to be preferred. 
Results
In all, 270 participants were enrolled on study. Of these, 
230 (85.2%) were recruited for subsample 1 and 40 (14.8%) 
were recruited for subsample 2. The characteristics of both 
subsamples are presented in Table 1.
structural validity
Table 2 displays the fit indices of the three models. The three 
models have very good fit indices. However, Model B exhib-
ited better fit than both Model A and Model C, as indexed by 
GFI and AGFI. Moreover, the AIC, BCC, and ECVI were 
strongly favorable to Model B (see Figure 1). 
As shown in Figure 1, the standardized factor loadings 
of Model B were all statistically significant (P0.01). Three 
items, however, showed loadings below 0.40 (ie, items 2, 3, 
and 8). Therefore, we also reran analyses with a new model 
similar to Model B but without these items. Even if a couple 
of fit indices tended to be better than those of previous mod-
els, this new model did not lead to any significant global 
improvement
 
(GFI =0.984; AGFI =0.972; PGFI =0.569; 
PRATIO =0.722). In order to be consistent with the initial 
scale, we did not exclude these items. The items are presented 
in Table S1.
Descriptive statistics, internal consistency 
reliability, and external validity
Cronbach α coefficients for both Factor 1 (α =0.90, total 
score, mean 16.5±9.9) and Factor 2 (α =0.80, total score, 
mean 20.8±8.0) were higher than 0.75, suggesting good 
scale and subscale reliability.56 Table 3 displays the correla-
tions between the QSU-12 subscales and other measures. 
Both subscales were strongly correlated with the global 
score. They were also positively and significantly related 
to cigarette consumption, FTND, loss of control (ie, dif-
ficulty in not smoking) and frequency of intrusive thoughts 
related to smoking behaviors. Moreover, r-to-Z Fisher score 
transformation57 indicated that the FTND was significantly 
more related to Factor 1 than to Factor 2 of the QSU-12 
(Z [270] =2.065, P0.05). Moreover, the frequency of 
intrusive thoughts related to smoking behaviors was more 
significantly related to Factor 1 than to Factor 2 of the 
QSU-12 (Z [230] =2.384, P0.05). Factor 1 was significantly 
and positively related to the negative impact of tobacco smok-
ing on daily living, to the proneness to smoke in response to 
negative emotional contexts, and to the number of years of 
smoking. No other correlation was significant for the dimen-
sions of the QSU-12.
Discussion
The current study examined the psychometric properties of 
a French version of the QSU-12. Results showed that the 
Table 1 Participants’ characteristics
Subsample 1 
(n=230)
Subsample 2 
(n=40)
age (years), mean (sD) 32.3 (11.4) 38.9 (11.2)
Female, % 62.6 52.5
highest degree, % University
college 
high school
Middle school
elementary school
62.2
20.0
11.3
6.1
0.4
20.0
30.0
47.5
0.0
2.5
Nationality, % Belgium
France
Other countries
34.8
57.4
7.8
100.0
0.0
0.0
Time elapsed since the last cigarette, % 15 minutes
15–30 minutes
30–60 minutes
1–2 hours
2–4 hours
4 hours
19.6
10.0
13.5
27.5
15.7
15.7
0.0
0.0
0.0
5.0
70.0
25.0
FTND, mean (sD) 3.1 (2.6) 3.5 (2.1)
Number of cigarettes smoked per day, mean (sD) 13.1 (10.0) 14.0 (5.8)
consume cannabis occasionally, % 12.6 0.0
carbon monoxide (ppm), mean (sD) No data 12.2 (5.4)
Abbreviations: FTND, Fagerström Test for Nicotine Dependence; ppm, parts per million of expired air; sD, standard deviation.
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Figure 1 Path diagram depicting the correlated two-factor solution (Model B) of the short French version of the Questionnaire on smoking Urges.
Notes: *P0.01. For each item, e represents the error measurement related to that specific item.
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0.67
4*
0.134
*
0.499*
0.641*
0.355*
0.670*
0.214
*
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Relief of negative
affect
(Factor 1)
Item 1
Item 2
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Item 10
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Item 8
Item 11
e10
e11
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Intention and
desire to smoke
(Factor 2)
e1
e2
e3
e4
e5
e6
e7
e8
e9
Table 2 Fit index values for the different tested models
Model df GFI AGFI PGFI PRATIO AIC BCC ECVI
a 54 0.970 0.957 0.671 0.818 444.892 447.330 1.654
B 53 0.978 0.967 0.664 0.803 378.049 380.589 1.405
c 53 0.974 0.962 0.662 0.803 421.568 424.107 1.567
Note: We considered Model B (emphasized by bold font) to be the best fitting model.
Abbreviations: agFi, adjusted goodness-of-Fit index; aic, akaike information criterion; Bcc, Browne–cudeck criterion; df, degree of freedom; ecVi, expected cross-
Validation index; gFi, goodness-of-Fit index; PgFi, Parsimony goodness-of-Fit index; PraTiO, Parsimony ratio.
correlated two-factor solution derived from the long French 
version of the QSU27 best fits the data, in comparison to 
the single-factor solution suggested by Kozlowski et al28 as 
well as the correlated two-factor solution derived from the 
English versions of the scale.17,33 The first factor assesses 
the urgency to smoke to relieve withdrawal and/or nega-
tive affect, whereas the second factor assesses the intention 
and desire to smoke. A good internal consistency was also 
observed.
In regard to the growing development of short assessment 
methods for clinical and research use, some methodological 
guidelines have been proposed to ensure the validity of such 
abbreviated forms.58 One of them highlights the importance 
of showing that a reduction in the questionnaire constitutes 
a trade-off between gained assessment time and induced 
loss of validity. We thus sought to evaluate this trade-off in 
the present study. On the one hand, assuming that approxi-
mately 15 seconds are necessary to fill out one item of the 
QSU, the completion time of the original 32-item scale is 
8 minutes, whereas the short version takes only 3 minutes to 
complete. On the other hand, we found the QSU-12 to have 
a similar structure to the original French scale. Moreover, 
the internal reliability coefficients of the QSU-12 remained 
satisfactory. Finally, convergent validity was shown through 
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the relationships with both a global scale of tobacco depen-
dence and the items measuring addiction-related symptoms 
(eg, smoking in affective contexts, loss of control, intrusive 
thoughts, and adverse consequences in daily life). Taken 
together, these results support the use of the QSU-12 for a 
meaningful timesaving. 
Relations were observed between the QSU-12 subscales 
and addiction symptoms. We found a correlation between 
both factors and loss of control (ie, difficulty in not smoking, 
more especially for Factor 1). This correlation is consistent 
with the literature, because craving has been shown to predict 
smoking lapses.9 Both factors were also associated with the 
frequency of intrusive thoughts or mental images related to 
smoking. This finding makes sense in view of recent models 
that consider intrusion and mental images’ elaboration as 
central to craving episodes.4,16
Dimensions of craving were related to dependence and 
to the number of cigarettes smoked per day. However, 
dimensions of craving were not significantly related to the 
time since the last cigarette. In the validation of the original 
version of the QSU, the authors manipulated the time since 
the last cigarette and found an overall increase of craving 
for both factors of the QSU from 0–6 hours of abstinence. 
In the current study, the time since the last cigarette is 
strongly related to the mean number of cigarettes per day. 
The absence of correlation should thus be interpreted cau-
tiously, as we did not manipulate it and thus did not capture 
the distribution of the variables when the individual engaged 
in a longer abstinence period than usual.17 Moreover, dimen-
sions of craving were not significantly related to CO. This 
absence of relation highlights the fact that craving cannot 
be considered as solely the result of a biological measure, 
such as expired CO or a potential deficit in nicotine, but as 
a complex and multidetermined phenomenon that also relies 
on psychological variables such as expectancies, beliefs, the 
affective state, and motivation. The multidimensional nature 
of craving has been developed in the elaborated intrusion 
theory of desire.4–16
Interestingly, Factor 1 (craving related to the relief 
of withdrawal and/or negative affect), which is closely 
related to dependence (as measured by the FTND), was 
the only dimension positively associated with the nega-
tive impact of tobacco on daily life, with the frequency 
of smoking triggered by negative emotional contexts and 
with the smoking history. In other words, high scores on 
this dimension characterized more-dependent smokers 
who reported stronger experience of the negative impact 
of tobacco, more frequent smoking in response to nega-
tive emotional contexts, and a longer smoking history. In 
contrast, Factor 2 (intention and desire to smoke), was 
less related to problematic outcomes (eg, no relation with 
negative impact in the daily life, relations of smaller ampli-
tudes with dependence symptoms and lack of control). 
Accordingly, this factor may represent a type of craving, 
less intense and more focused on positive reinforcement 
(as reflected by items 3 and 8), likely to be experienced 
by smokers with low dependence levels and who initiated 
smoking more recently. 
It is worth noting that in contrast with analyses realized 
on the English version of the QSU and consistent with those 
related to the French version, item 9 (“I have an urge for a 
cigarette”) loaded on Factor 1. This is due to an inaccurate 
translation of this item by Guillin et al27 when they developed 
the French QSU. Indeed, the word “urge” has been translated 
in French in a way that suggests an “urgent need” rather than 
a “strong desire”. Thus, the words used in this translation 
seem more closely related to the anticipation of relief of 
discomfort as compared with the words used in the English 
version that are more tightly related to the anticipation of 
positive outcomes.
A first limitation to this study is that no information was 
collected regarding the potential motivation for smoking 
cessation and previous quit attempts. In the same vein, we 
did not collect any information regarding potential comorbid 
psychiatric disorders (eg, alcohol-dependence, pathological 
gambling, anxiety), thereby limiting the generalizability of 
the present findings. A second limitation is that our sample 
was composed of relatively low smokers (with regard to 
the FTND score). However, our results suggest that the 
more the participants have high FTND scores, the more 
the experience elevated levels of craving, especially on 
the relief from negative affect dimension. Our study might 
thus underestimate mechanisms that are more inherent to 
high levels of craving. A third limitation is that three items 
exhibit loadings lower than 0.40. Even if the suppression of 
those items did not lead to any important change in the pres-
ent sample, future studies should further examine whether 
these items provide enough information. One interesting 
way would be the use, among a new sample of smokers, 
of an item-analysis approach modeling the probability of a 
specified item’s response through logistic functions of the 
difference between the person and item parameters, such as 
those mathematical approaches derived from Rash model59 or 
artificial neural networks.60 Finally, we did not manipulate 
the time lag between the last cigarette and the completion of 
the questionnaires. This would have allowed capturing the 
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transient and changing nature of craving across time.12,61 
Future studies should further examine this question. 
On the whole, the current study showed that the 
QSU-12 is a useful instrument for assessing the multidi-
mensional construct of cigarette craving. The time saved 
thanks to the item-number reduction improves the clinical 
and research feasibility of this tool.
Acknowledgments
The authors thank Arnaud Carré and all the members of 
the Groupe de Réflexion en Psychopathologie Cognitive 
(GREPACO) for their help in disseminating the study proto-
col. We would also like to thank Melissa Morales-Duarte for 
her help in data collection and the members of the Laboratory 
for Experimental Psychopathology for their useful comments 
on a preliminary draft of the article. 
Disclosure
This work has been partly supported by Université catholique 
de Louvain (Belgium) and by a grant (grant number FC 
78142) from the Belgian National Fund for Scientific 
Research (awarded to Alexandre Heeren). These funding 
bodies did not exert any editorial direction or censorship 
on any part of this article. All authors report no competing 
financial interests or potential conflicts of interest, and no 
financial relationships with commercial interests. The authors 
report no other conflicts of interest in this work.
References
 1. World Health Organization. The ICD-10 Classification of Mental and 
Behavioural Disorders: Clinical Descriptions and Diagnostic Guide-
lines. Geneva, Switzerland: World Health Organization; 1992. 
 2. American Psychiatric Association. Diagnostic and Statistical Manual 
of Mental Disorders. 5th ed. Washington, DC: American Psyciatric 
Publishing; 2013. 
 3. Drummond DC. Theories of drug craving, ancient and modern. Addic-
tion. 2001;96(1):33–46. 
 4. Kavanagh DJ, Andrade J, May J. Imaginary relish and exquisite 
torture: the elaborated intrusion theory of desire. Psychol Rev. 2005; 
112(2):446–467. 
 5. Robinson TE, Berridge KC. Incentive-sensitization and addiction. 
Addiction. 2001;96(1):103–114. 
 6. Tiffany ST. A cognitive model of drug urges and drug-use behavior: 
Role of automatic and nonautomatic processes. Psychol Rev. 1990;97(2): 
147–168. 
 7. Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal 
severity mediate nicotine patch efficacy? A randomized clinical trial. 
J Consult Clin Psychol. 2006;74(6):1153–1161. 
 8. Killen JD, Fortmann SP. Craving is associated with smoking relapse: 
findings from three prospective studies. Exp Clin Psychopharmacol. 
1997;5(2):137–142. 
 9. Shiffman S, Engberg JB, Paty JA, et al. A day at a time: predicting smoking 
lapse from daily urge. J Abnorm Psychol. 1997;106(1):104–116. 
 10. Franklin T, Wang Z, Suh JJ, et al. Effects of varenicline on smoking 
cue–triggered neural and craving responses. Arch Gen Psychiatry. 
2011;68(5):516–526. 
 11. Hartwell KJ, Lematty T, McRae-Clark AL, Gray KM, George MS, 
Brady KT. Resisting the urge to smoke and craving during a smoking 
quit attempt on varenicline: results from a pilot fMRI study. Am J Drug 
Alcohol Abuse. 2013;39(2):92–98. 
 12. Tiffany ST, Wray JM. The clinical significance of drug craving. Ann 
N Y Acad Sci. 2012;1248:1–17. 
 13. Brandon TH, Wetter DW, Baker TB. Affect, expectancies, urges, and 
smoking: do they conform to models of drug motivation and relapse? 
Exp Clin Psychopharmacol. 1996;4(1):29–36. 
 14. Kozlowski LT, Wilkinson DA. Use and misuse of the concept of crav-
ing by alcohol, tobacco, and drug researchers. Br J Addict. 1987;82(1): 
31–45. 
 15. Cepeda-Benito A, Henry K, Gleaves DH, Fernandez MC. Cross-cultural 
investigation of the Questionnaire of Smoking Urges in American and 
Spanish smokers. Assessment. 2004;11(2):152–159. 
 16. May J, Andrade J, Panabokke N, Kavanagh D. Images of desire: cogni-
tive models of craving. Memory. 2004;12(4):447–461. 
 17. Tiffany ST, Drobes DJ. The development and initial validation of a ques-
tionnaire on smoking urges. Br J Addict. 1991;86(11):1467–1476. 
 18. Dawkins L, Powell JH, West R, Powell J, Pickering A. A double-blind 
placebo controlled experimental study of nicotine: I – effects on incen-
tive motivation. Psychopharmacology (Berl). 2006;189(3):355–367. 
 19. Haasova M, Warren FC, Ussher M, et al. The acute effects of physical 
activity on cigarette cravings: systematic review and meta-analysis with 
individual participant data. Addiction. 2013;108(1):26–37. 
 20. Janse Van Rensburg K, Taylor A, Benattayallah A, Hodgson T. The 
effects of exercise on cigarette cravings and brain activation in response 
to smoking-related images. Psychopharmacology (Berl). 2012;221(4): 
659–666. 
 21. Ussher M, Aveyard P, Manyonda I, et al. Physical activity as an aid to 
smoking cessation during pregnancy (LEAP) trial: study protocol for 
a randomized controlled trial. Trials. 2012;13:186. 
 22. Rosenberg H. Clinical and laboratory assessment of the subjec-
tive experience of drug craving. Clin Psychol Rev. 2009;29(6): 
519–534. 
 23. Davies GM, Willner P, Morgan MJ. Smoking-related cues elicit craving 
in tobacco “chippers”: a replication and validation of the two-factor 
structure of the Questionnaire of Smoking Urges. Psychopharmacology 
(Berl). 2000;152(3):334–342. 
 24. Weinberger AH, Reutenauer EL, Allen TM, et al. Reliability of 
the Fagerström Test for Nicotine Dependence, Minnesota Nicotine 
Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in 
smokers with and without schizophrenia. Drug Alcohol Depend. 2007; 
86(2–3):278–282. 
 25. Cepeda-Benito A, Reig-Ferrer A. Development of a brief questionnaire 
of smoking urges – Spanish. Psychol Assess. 2004;16(4):402–407. 
 26. Müller V, Mucha RF, Ackermann K, Pauli P. Die erfassung des crav-
ings bei rauchern mit einer deutschen version des “Questionnaire on 
smoking urges” (QSU-G) [The assessment of craving in smokers with 
a German version of the “Questionnaire on Smoking Urges” (QSU-G)]. 
Z Klin Psychol Psychother. 2001;30(3):164–171. German.
 27. Guillin O, Krebs MO, Bourdel MC, Olie JP, Loo H, Poirier MF. [Valida-
tion of the French translation and factorial structure of the Tiffany and 
Drobes Smoking Urge Questionnaire]. L’Encephale. 1999;26(6):27–31. 
French. 
 28. Kozlowski LT, Pillitteri JL, Sweeney CT, Whitfield KE, Graham JW. 
Asking questions about urges or cravings for cigarettes. Psychol Addict 
Behav. 1996;10(4):248–260. 
 29. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief question-
naire of smoking urges (QSU-brief) in laboratory and clinical settings. 
Nicotine Tob Res. 2001;3(1):7–16. 
 30. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, 
Gilbert DG. Multivariate framework of the Brief Questionnaire of 
Smoking Urges. Drug Alcohol Depend. 2007;90(2–3):234–242. 
 31. Clausius RL, Krebill R, Mayo MS, et al. Evaluation of the brief ques-
tionnaire of smoking urges in Black light smokers. Nicotine Tob Res. 
2012;14(9):1110–1114. 
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
8.
64
.7
9.
10
 o
n 
08
-F
eb
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment 2014:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1467
Probing smoking craving
 32. Toll BA, Katulak NA, McKee SA. Investigating the factor structure of 
the Questionnaire on Smoking Urges-Brief (QSU-Brief). Addict Behav. 
2006;31(7):1231–1239. 
 33. Toll BA, McKee SA, Krishnan-Sarin S, O’malley SS. Revisiting the 
factor structure of the questionnaire on smoking urges. Psychol Assess. 
2004;16(4):391–395. 
 34. Araujo RB, Oliveira MDS, Moraes JFD, Pedroso RS, Port F, De Castro 
MDGTD. Validação da versão brasileira do Questionnaire of Smoking 
Urges-Brief [Validation of the Brazilian version of Questionnaire of 
Smoking Urges-Brief]. Revista de Psiquiatria Clinica. 2007;34(4): 
166–175. Portuguese. 
 35. Teneggi V, Oprandi N, Milleri S, et al. Verifica della validità esteriore 
e del contenuto della versione italiana di tre questionari su craving e 
astinenza da fumo di sigarette [Assessment of face and content validity 
of the Italian version of three questionnaires on cigarette smoke crav-
ing and withdrawal]. Giornale di Psicopatologia. 2001;7(4):378–386. 
Italian.
 36. Yu X, Xiao D, Li B, et al. Evaluation of the Chinese versions of the 
Minnesota nicotine withdrawal scale and the questionnaire on smoking 
urges-brief. Nicotine Tob Res. 2010;12(6):630–634. 
 37. Berlin I, Singleton EG. Nicotine dependence and urge to smoke 
predict negative health symptoms in smokers. Prev Med. 2008;47(4): 
447–451. 
 38. Billieux J, Gay P, Rochat L, Khazaal Y, Zullino D, Van der Linden M. 
Lack of inhibitory control predicts cigarette smoking dependence: 
evidence from a non-deprived sample of light to moderate smokers. 
Drug Alcohol Depend. 2010;112(1–2):164–167. 
 39. Billieux J, Van der Linden M, Ceschi G. Which dimensions of impul-
sivity are related to cigarette craving? Addict Behav. 2007;32(6): 
1189–1199. 
 40. Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the 
use of exploratory factor analysis in psychological research. Psychol 
Methods. 1999;4(3):272–299.
 41. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The 
Fagerström Test for Nicotine Dependence: a revision of the Fagerström 
Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–1127. 
 42. Benowitz NL. The use of biologic fluid samples in assessing tobacco 
smoke consumption. NIDA Res Monogr. 1983;48:6–26. 
 43. Byrne BM. Structural Equation Modeling with EQS and EQS/Windows. 
Thousand Oaks, CA: Sage Publications, Inc.; 1994. 
 44. Mardia KV. Applications of some measures of multivariate skewness 
and kurtosis in testing normality and robustness studies. Sankhya¯: The 
Indian Journal of Statistics. 1974;36(Series B, Pt 2):115–128. 
 45. McDonald RP, Ho MH. Principles and practice in reporting structural 
equation analyses. Psychol Methods. 2002;7(1):64–82. 
 46. Heeren A, Douilliez C, Peschard V, Debrauwere L, Philippot P. Validité 
transculturelle du Five Facets Mindfulness Questionnaire: adaptation 
et validation auprès d’un échantillon francophone [Cross-cultural 
consistency of the Five Facets Mindfulness Questionnaire: adaptation 
and validation in a French-speaking sample]. Revue Européenne de 
Psychologie Appliquée. 2011;61(3):147–151. French.
 47. Browne MW. Covariance structures. In: Hawkins DM, editor. Topics in 
Applied Multivariate Analysis. Cambridge, UK: Cambridge University 
Press; 1982:72–141. 
 48. Jöreskog KG, Sörbom D. LISREL 7: A Guide to the Program and 
Applications. 2nd ed. Chicago, IL: SPSS Inc; 1989. 
 49. Hoyle RH, Panter AT. Writing about structural equation models. In: 
Hoyle RH, editor. Structural Equation Modeling: Concepts, Issues, 
and Applications. Thousand Oaks, CA: Sage Publications, Inc.; 1995: 
158–176. 
 50. Marsh HW, Balla JR, McDonald RP. Goodness-of-fit indices in 
confirmatory factor analysis: the effects of sample size. Psychol Bull. 
1988;103(3):391–410. 
 51. Cole DA. Utility of confirmatory factor analysis in test validation 
research. J Consult Clin Psychol. 1987;55(4):584–594. 
 52. James CR, Mulaik SA, Brett JM. Causal Analysis: Assumptions, Models 
and Data. Beverley Hills, CA: Sage Publications, Inc.; 1982. 
 53. Blunch NJ. Introduction to Structural Equation Modeling Using SPSS 
and AMOS. London, UK: Sage Publications, Ltd.; 2008. 
 54. Akaike H. Factor analysis and AIC. Psychometrika. 1987;52: 
317–332. 
 55. Browne MW, Cudeck R. Single sample cross-validation indices for 
covariance structures. Multivariate Behav Res. 1989;24(4):445–455. 
 56. Nunnally JC. Psychometric Theory. 2nd ed. New York, NY: McGraw-
Hill, Inc; 1978. 
 57. Steiger JH. Tests for comparing elements of a correlation matrix. 
Psychol Bull. 1980;87(2):245–251. 
 58. Smith GT, McCarthy DM, Anderson KG. On the sins of short-form 
development. Psychol Assess. 2000;12(1):102–111. 
 59. Rasch G. Probabilistic Models for Some Intelligence and Attainment 
Tests. Expanded ed. Chicago, IL: The University of Chigago Press; 
1980. 
 60. Shu Z, Henson R, Willse J. Using neural network analysis to define 
methods of DINA model estimation for small sample sizes. J Classif. 
2013;30(2):173–194. 
 61. Tiffany ST, Warthen MW, Goedeker KC. The functional significance of 
craving in nicotine dependence. Nebr Symp Motiv. 2009;55:171–197. 
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
8.
64
.7
9.
10
 o
n 
08
-F
eb
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journal
Neuropsychiatric Disease and Treatment is an international, peer-
reviewed journal of clinical therapeutics and pharmacology focusing 
on concise rapid reporting of clinical or pre-clinical studies on a 
range of neuropsychiatric and neurological disorders. This journal 
is indexed on PubMed Central, the ‘PsycINFO’ database and CAS, 
and is the official journal of The International Neuropsychiatric 
 Association (INA). The manuscript management system is completely 
online and includes a very quick and fair peer-review system, which 
is all easy to use. Visit http://www.dovepress.com/testimonials.php to 
read real quotes from published authors.
Dovepress
Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1468
Dethier et al
Supplementary material
Table S1 QsU-12 items
Item Factor
 1. Nothing would be better than smoking a cigarette right now F1
 2. smoking would make me less depressed F1
 3. smoking a cigarette would not be pleasant* F2
 4. all i want right now is a cigarette F1
 5. even if it were possible, i probably would not smoke now* F2
 6. i have no desire for a cigarette right now* F2
 7. smoking now would make things seem just perfect F1
 8. a cigarette would not taste good right now* F2
 9. i have an urge for a cigarette F1
10. i could control things better if i could smoke right now F1
11. i am going to smoke as soon as possible F2
12. i would do almost anything for a cigarette right now F1
Notes: The French translation of these items can be obtained on request by mail or on the website of the laboratory for experimental Psychopathology: http://uclep.be. 
*reversed items.
Abbreviations: F1, Factor 1: relief of negative affect; F2, Factor 2: intention and desire to smoke; QsU-12, 12-item version of the Questionnaire on smoking Urges.
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